Inventor

AMBERG WILHELM

DE64 patents

⚠️ This page may combine multiple inventors who share the name “AMBERG WILHELM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMBERG WILHELM

BASF AG

Carboxylic acid derivatives, their preparation and use

Carboxylic acid derivatives, their preparation and use

Carboxylic acid derivatives, their preparation and use

Carboxylic acid derivatives, their preparation and use

Carboxylic acid derivatives, their production and use

Dolastatin 15 derivatives

Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus

Preparation of active peptides

Compounds useful for the synthesis of dolastatin analogs

Carboxylic acid derivatives, their preparation and their use

Compounds useful for the synthesis of dolastatin analogs

Active peptide and its preparation

Oligopeptides, the preparation and use thereof

Method for preparing sulfanyl-type endothelin receptor antagonists

ABBOTT GMBH & CO KG

Carboxylic acid derivatives, their preparation and use

Carboxylic acid derivatives, their preparation and their use

Carboxylic acid derivatives, their preparation and use

Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists

Antineoplastic peptides

Antineoplastic peptides

Carboxylic acid derivatives, their preparation and use

Carboxylic acid derivatives, their preparation and use

Carboxylic acid derivatives, their preparation and use

Carboxylic acid derivatives, their preparation and use

α-hydrdroxylic acid derivatives, their production and use

ABBVIE DEUTSCHLAND

Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

AMBERG WILHELM

4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

Heterocyclic compounds and their use as binding partners for 5-HT5 receptors

5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors

Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy

ABBOTT LAB

Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists

Heterocyclically substituted α-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

Amino acid derivatives, the preparation and use thereof as endothelin antagonists

Carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists

LANGE UDO

Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

NETZ ASTRID

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

POHLKI FRAUKE

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

OCHSE MICHAEL

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

GENESTE HERVE

Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

ABBVIE INC

Fused heterocyclic compounds as S1P modulators